-
Marein Blocks ABCG2 to Restore Drug Sensitivity
2026-09-26
A 2024 study identifies marein, a flavonoid from Coreopsis tinctoria, as a competitive inhibitor of the ABCG2 drug-efflux transporter. By increasing intracellular levels of ABCG2-substrate drugs, marein sensitized transporter-expressing cancer cells to topotecan, Mitoxantrone, and olaparib, with F439 implicated in the interaction.
-
Levofloxacin: From Mechanism to Translational Strategy
2026-09-26
A translational framework for using Levofloxacin to investigate bacterial DNA replication while designing rigorous osteoblast and chondrocyte studies. Connect mechanism, assay selection, resistance-aware interpretation, and practical compound handling without confusing research findings with clinical guidance.
-
Reading DNA Damage in the FLASH-RT Era
2026-09-25
FLASH radiotherapy research raises a translational question: how can teams distinguish a promising treatment effect from a reproducible DNA damage response? This article connects γ-H2AX biology with experimental design, discusses findings from EGCG nanoparticle-assisted FLASH-RT research, and outlines how immunofluorescence can support—without overclaiming—mechanistic interpretation.
-
Salvianolic Acid B in Pulmonary Fibrosis Research
2026-09-25
Use Salvianolic acid B to test how reduced LH2 expression may alter collagen cross-linking and fibrotic remodeling—not simply total collagen abundance. This practical workflow pairs pathway and phenotype readouts with fresh-compound handling, vehicle controls, and pilot conditions clearly separated from published findings.
-
WEHI-539: A BCL-XL Inhibitor Workflow
2026-09-24
WEHI-539 provides a selective way to test whether cancer cells rely on BCL-XL to suppress mitochondrial apoptosis. This practical workflow pairs careful formulation checks with pathway-focused controls, helping distinguish BCL-XL dependence from broader apoptotic resistance.
-
Thapsigargin Workflows for Calcium and ER Stress
2026-09-24
Thapsigargin is a potent SERCA pump inhibitor for separating rapid calcium responses from longer-term ER stress and cell-death outcomes. This workflow guide covers practical dose planning, controls, readouts, and troubleshooting, with clear distinctions between product data and suggested starting conditions.
-
TPCA-1 in Septic AKI: NF-κB to Autophagy
2026-09-23
Explore how TPCA-1, a selective IKK-2 inhibitor, can serve as a mechanistic probe of the NF-κB/Apaf1/caspase-9/autophagy axis in septic acute kidney injury research. This article translates recent renal findings into a rigorous assay and interpretation framework.
-
Mitochondrial Calcium Signaling Represses Ferroptosis
2026-09-23
The reference study identifies a mechanistic link between mitochondrial calcium uptake, acetyl-CoA availability, GPX4 acetylation, and suppression of ferroptosis. Genetic, biochemical, structural, and tumor-model evidence suggests that MCU sustains GPX4 activity and can influence ferroptosis sensitivity in cancer cells.
-
HCAR3 Structures Reveal Agonist Selectivity
2026-09-22
Ye et al. use cryo-EM structures and cAMP signaling assays to explain how HCAR3 recognizes several agonists and differs from HCAR2. The study identifies pocket geometry and residue-specific aromatic interactions that may guide HCAR3-directed lipid metabolism research while reducing HCAR2-associated flushing mechanisms.
-
WDR36, Glycolysis, and Human TE Differentiation
2026-09-21
The reference study identifies WDR36 as a regulator of human trophectoderm differentiation in a pluripotent stem cell-derived blastoid model. Its integrated perturbation, transcriptomic, metabolomic, and protein-interaction evidence connects WDR36 with LDHA-associated glycolysis during late blastoid formation, while also defining important limits for extrapolation to human embryos.
-
MLKL Polymerization and Cathepsin B in Necroptosis
2026-09-21
This reference study identifies lysosomal membrane permeabilization as a key execution step between MLKL polymerization and necroptotic cell death. Using live-cell imaging, MLKL-domain experiments, and cathepsin B perturbation, the authors show that lysosomal rupture releases cathepsin B, which contributes to the cleavage of proteins required for cell survival.
-
γH2AX DNA Damage Detection Kit Workflow
2026-09-20
Translate radiation-, nanoparticle-, and drug-associated DNA damage into spatially resolved red γ-H2AX foci with a practical immunofluorescence workflow. This guide connects the assay to FLASH-RT radiosensitization, DNA repair kinetics, apoptosis assay design, and genotoxicity assessment while emphasizing controls and troubleshooting.
-
EHEC Delays Danazol- and Diet-Induced Precocious Puberty
2026-09-19
A 2025 rat study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in two models of precocious puberty triggered by Danazol or a high-fat diet. The extract delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without altering body weight, supporting further investigation of HPG-axis modulation while leaving important translational questions unresolved.
-
STL427944 Targets FOXM1 to Reverse Chemoresistance
2026-09-19
The reference study identifies STL427944 through gene network and transcriptomic analysis as a selective FOXM1 inhibitor. Rather than blocking FOXM1 only at the transcriptional level, the compound relocalizes nuclear FOXM1 to the cytoplasm and promotes autophagy-dependent degradation, increasing cancer-cell sensitivity to platinum drugs, 5-fluorouracil, and taxanes.
-
CRTC-CREB Sensing of Proteotoxic Stress in Drosophila
2026-09-18
The reference study identifies the CRTC-CREB axis as a stress-responsive transcriptional system activated by proteasome inhibition through ROS and JNK signaling. Its Drosophila and cell-based experiments connect this pathway to redox control, proteostasis, protein aggregation, and functional rescue in a Huntington’s disease model.